General Capabilities Overview: Built Through Experience, Delivered By People

Bring complex therapies from development through commercial production with an experienced contract manufacturing network built for quality, flexibility, and reliable supply. End-to-end capabilities span biologics, nucleic acid therapies, cell and gene therapies, small molecules, and aseptic fill and finish, supported by process development and analytical expertise. Manufacturing options include mammalian production up to 15 kL, microbial production up to 40 kL, viral vectors, cell therapies, oral solid dosage forms, and a wide range of packaging systems. More than 20 global manufacturing sites provide access to specialized infrastructure across the United States, Europe, and Asia. With over 40 years of GMP manufacturing experience and more than 100 successful inspections each year, the network helps teams navigate regulatory requirements while delivering complex products with uncompromising quality.

Explore the full capabilities and available manufacturing locations.